Sacral Neuromodulation for Bowel and Sexual Functions
US-2024424299-A1 · Dec 26, 2024 · US
US9764128B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9764128-B2 |
| Application number | US-201414322172-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 2, 2014 |
| Priority date | Jul 2, 2013 |
| Publication date | Sep 19, 2017 |
| Grant date | Sep 19, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method of identifying a location for applying a stimulation therapy to treat a patient includes stimulating a first body region of the patient transcutaneously via a stimulus generator. The body region contains a first portion of a nerve that has an elongate shape. In response to the stimulating, action potentials received from a second portion of the nerve are monitored over a period of time. The second portion of the nerve is in a second body region of the patient that is located remotely from the first body region. Based on the monitoring, an optimized location of the second portion of the nerve is determined for applying the stimulation therapy to treat the first body region.
Opening claim text (preview).
What is claimed is: 1. A method of identifying a location for applying a stimulation therapy to treat a patient, the method comprising: stimulating a first body region of the patient transcutaneously via a stimulus generator, wherein the first body region includes a foot that contains a first portion of a nerve that has an elongate shape; monitoring, in response to the stimulating, action potentials received from a second portion of the nerve over a period of time, wherein the second portion of the nerve is in a second body region of the patient includes a thigh, and wherein the monitoring comprises engaging different fascicles of the second portion of the nerve as the first body region is being stimulated; and determining, based on the monitoring, an optimized location of the second portion of the nerve for applying the stimulation therapy to treat the first body region. 2. The method of claim 1 , wherein a different action potential is received each time a different fascicle is engaged. 3. The method of claim 1 , wherein the engaging is performed at least in part via a needle or a paddle lead, each of which is configured to engage with the second portion of the nerve and receive the action potential arising therefrom. 4. The method of claim 3 , further comprising: inserting a percutaneous lead through the needle; and placing the percutaneous lead at the optimized location of the second portion of the nerve. 5. The method of claim 4 , further comprising, before the placing of the lead: applying, through the needle, electrical stimulation to the optimized location of the second portion of the nerve; and detecting a response from the first body region. 6. The method of claim 1 , wherein the monitoring is performed via an instrument that is configured to measure electrical signals including the action potentials, and wherein the method further comprises sending a trigger signal to the instrument, the trigger signal specifying a time window within which the monitoring is performed. 7. The method of claim 1 , wherein the determining comprises: identifying a greatest action potential among the action potentials received from the second portion of the nerve; and selecting a location of the second portion of the nerve that corresponds to the greatest action potential as the optimized location. 8. The method of claim 1 , wherein the stimulating, the monitoring, and the determining are performed without receiving feedback from the patient. 9. The method of claim 1 , wherein the monitoring is performed at least in part by using an indifferent electrode as a reference, the indifferent electrode being placed in a third body region remotely located from the first body region and the second body region. 10. A method of identifying a location for applying a stimulation therapy to treat a patient, the method comprising: stimulating a first body region of the patient via an external pulse generator (EPG), the body region including a foot that contains a first portion of a nerve that has an elongate shape; sending a trigger signal to a measurement instrument, the trigger signal defining a time window for making a measurement; and measuring a plurality of different action potentials via the measurement instrument, the measuring being performed in response to a plurality of engagements with different fascicles of a second portion of the nerve while the first body region is stimulated, wherein the second portion of the nerve is in a second body region of the patient that is located in an upper leg, wherein the measuring is performed within the time window defined by the trigger signal, and wherein the stimulating, the sending, and the measuring are performed while the patient is sedated. 11. The method of claim 10 , further comprising: selecting, based on the measured action potentials, one of the fascicles that offered a greatest action potential as a target location of the second portion of the nerve for applying the stimulation therapy to treat the first body region. 12. The method of claim 11 , further comprising: receiving the different action potentials with one of: a seeking needle or a paddle lead. 13. The method of claim 12 , further comprising: inserting a percutaneous lead through the needle; and placing the percutaneous lead on the target location of the second portion of the nerve. 14. The method of claim 10 , wherein the measuring is performed at least in part by using a reference electrode that is placed in a third body region remotely located from the first body region and the second body region. 15. A medical system, comprising: a stimulus generator configured to apply stimulation to a foot of a patient, the foot containing a first portion of an elongate nerve; a tool configured to engage with a second portion of the nerve that is in a thigh of the patient, wherein the tool is configured to receive action potentials from the second portion of the nerve in response to the stimulation at the foot of the patient, and wherein the tool includes one of: a seeking needle or a paddle lead; and a measurement instrument electrically coupled to the tool and configured to measure and analyze the action potentials received by the tool. 16. The medical system of claim 15 , further comprising a telecommunications link between the stimulus generator and the measurement instrument, wherein the stimulus generator is configured to send, via the telecommunications link, a trigger signal to the measurement instrument, and wherein the measurement instrument is configured to measure the action potentials within a time window specified by the trigger signal. 17. The medical system of claim 15 , wherein the measurement instrument contains a processor configured to: analyze the action potentials received by the tool in response to a plurality of engagements with different fascicles of the second portion of the nerve while the stimulation is applied to the foot, the engagements with the different fascicles being made via the seeking needle or the paddle lead; and determine, based on the analysis, an optimized location of the second portion of the nerve for applying a stimulation therapy to treat the patient. 18. The medical system of claim 15 , further comprising a percutaneous lead that is configured to be inserted through the lead and placed on the second portion of the nerve. 19. The medical system of claim 18 , further comprising: an implantable pulse generator (IPG) configured to apply a stimulation therapy to the second portion of the nerve through one of: the percutaneous lead or the paddle lead. 20. The medical system of claim 15 , further comprising: ultrasound equipment configured to display visual information regarding an engagement of the tool with the second portion of the nerve.
using markers (A61B5/062 takes precedence) · CPC title
Aspects of the external programmer · CPC title
Pain · CPC title
Paddle shaped electrodes, e.g. for laminotomy · CPC title
from an external energy source · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.